PTGS2 and cancer: A synergistic effect of the most active COX-1 inhibitor 1g with the known COX-2 selective inhibitor, celecoxib, was also observed (CI = 0.75), which may be indicative for the involvement of both cyclooxygenase isoenzymes in cancer cell development and the value of combined COX1/2 inhibition for best inhibitory effect.